Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours

BACKGROUND: This phase I study evaluated the safety, tolerability, maximum tolerated dose (MTD) and pharmacokinetics of two dosing schedules of oral topotecan in combination with pazopanib in patients with advanced solid tumours. METHODS: Stage I of this study was to determine whether there was an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerklaan, B Milojkovic, Lolkema, M P J, Devriese, L A, Voest, E E, Nol-Boekel, A, Mergui-Roelvink, M, Langenberg, M, Mykulowycz, K, Stoebenau, J, Lane, S, Legenne, P, Wissel, P, Smith, D A, Giantonio, B J, Schellens, J H M, Witteveen, P O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559826/
https://www.ncbi.nlm.nih.gov/pubmed/26291057
http://dx.doi.org/10.1038/bjc.2015.257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559826/
https://www.ncbi.nlm.nih.gov/pubmed/26291057
http://dx.doi.org/10.1038/bjc.2015.257

Ejemplares similares